Hybrid Conferencee

International Conference on Oncology, Immunotherapy and Precision Medicine (ICOIPM - 26)

4th - 5th November 2026 | Fes, Morocco

10% DISCOUNT

Maximum discount capped at $30. Activate your Scholarly Discount during the payment phase to lower your final checkout amount.

REVEAL OFFER
EARLY10
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Conference Notifications:

"Be sure to check this section regularly for all Research Plus International Conference updates. We’ll keep you informed about deadlines, event details, and more important notifications."

Call for Papers Extended:
"The deadline for full paper submissions has been extended for the Research Plus International Conference in Fes. Submit your research by today to participate in one of the top conferences."
Certificate of Presentation:
"Present your research and receive a Certificate of Presentation to recognise your valuable contribution to the conference."
Abstract Submissions Open:
"Abstract submissions for the Fes event are now open! Don’t miss the chance to present your research. Submit now."
Networking with Global Experts:
"Engage with researchers and professionals from around the world at the Fes conference. Build collaborations and gain insights from leading experts."
Keynote Speaker Sessions:
"Don’t miss our Keynote Sessions in Fes, featuring global leaders and innovators sharing their knowledge."
Best Paper & Best Paper Presentation Award:
"Submit your paper and stand a chance to win the Best Paper Presentation Award. The winner will be recognized at the conference in Fes."
SDG-Inspired Conference Focus:
"Our conference will highlight research that addresses global sustainability, inclusive education, and solutions for environmental challenges."

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 3
SDG 3 Good Health and Well-being
SDG 4
SDG 4 Quality Education
SDG 9
SDG 9 Industry, Innovation and Infrastructure
Track 01

Advancements in Immunotherapy for Cancer Treatment

This track will explore the latest breakthroughs in immunotherapy, focusing on novel approaches and therapies that harness the immune system to combat cancer. Discussions will include case studies and clinical trial results that highlight the efficacy and safety of these innovative treatments.

Track 02

Precision Medicine in Oncology: Tailoring Treatment Strategies

This session will delve into the principles of precision medicine in oncology, emphasizing the importance of personalized treatment plans based on genetic and molecular profiling. Participants will examine how these tailored strategies improve patient outcomes and reduce adverse effects.

Track 03

Biomarkers in Cancer Diagnosis and Prognosis

This track will focus on the role of biomarkers in the early detection and prognosis of various cancers. Presentations will highlight recent research findings that demonstrate how biomarkers can guide treatment decisions and improve patient management.

Track 04

Tumor Biology: Mechanisms and Therapeutic Targets

This session will investigate the underlying mechanisms of tumor biology, including cellular signaling pathways and tumor microenvironment interactions. The goal is to identify potential therapeutic targets that can be exploited for more effective cancer treatments.

Track 05

Translational Oncology: Bridging Research and Clinical Practice

This track will address the challenges and successes in translating basic cancer research into clinical applications. Discussions will focus on strategies to enhance collaboration between researchers and clinicians to expedite the development of new therapies.

Track 06

Clinical Trials: Innovations and Methodologies

This session will cover the design and implementation of clinical trials in oncology, highlighting innovative methodologies that improve trial efficiency and patient recruitment. Attendees will gain insights into the regulatory landscape and ethical considerations in conducting cancer research.

Track 07

Emerging Therapies in Cancer Treatment

This track will showcase emerging therapies in the oncology landscape, including targeted therapies and combination treatments. Participants will discuss the potential of these new modalities to improve survival rates and quality of life for cancer patients.

Track 08

Cancer Epidemiology and Risk Factors

This session will examine the epidemiological trends in cancer incidence and the associated risk factors. Presentations will focus on the implications of these findings for public health initiatives and cancer prevention strategies.

Track 09

Pediatric Oncology: Unique Challenges and Advances

This track will address the unique challenges faced in pediatric oncology, including the biological differences in childhood cancers and their treatment. Discussions will highlight recent advances in therapies and the importance of supportive care for young patients.

Track 10

Patient-Centered Approaches in Cancer Care

This session will explore the importance of patient-centered care in oncology, emphasizing the need for effective communication and shared decision-making. Participants will discuss strategies to enhance patient engagement and improve overall treatment satisfaction.

Track 11

Global Perspectives on Cancer Research and Treatment

This track will provide a platform for discussing global disparities in cancer research and treatment access. Participants will share insights on collaborative efforts and innovative solutions to address these challenges on an international scale.